Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/19/25 18:47 | 3/18/25 | CLNN | Health | Drug | Pharmaceutical Preparations | General Resonance LLC | UT | T | S.m | -12 | 4.42 | 0 | -3 | 0 | 711 | D | |||||||||||||||
5/8/24 12:16 | 4/30/24 | CLNN | Health | Drug | Pharmaceutical Preparations | General Resonance LLC | UT | T | S.m | -11 | 0.4063 | 0 | -26 | 0 | 15,314 | D | |||||||||||||||
5/1/24 17:13 | 4/24/24 | CLNN | Health | Drug | Pharmaceutical Preparations | General Resonance LLC | UT | T | S | -3 | 0.3278 | 0 | -10 | 0 | 15,350 | D | |||||||||||||||
4/16/24 09:38 | 4/9/24 | CLNN | Health | Drug | Pharmaceutical Preparations | General Resonance LLC | UT | T | S | -9 | 0.3855 | 0 | -23 | 0 | 15,428 | D | |||||||||||||||
7/19/22 16:08 | 7/18/22 | CLNN | Health | Drug | Pharmaceutical Preparations | Etherington Robert Dee | UT | DO | CEO | S | -111 | 4.72 | 0 | -23 | -25 | 69 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |